BullishAgent BullishAgent SEC Filings Earnings Calendar Analyst Ratings IPOs Insiders Institutional Funds Screener
Sign in Register

STT

State Street Corporation NYSE
Financial Services ·Asset Management ·US · statestreet.com
$152.00
After hrs $148.08 +0.00%
Mkt Cap $43.9B
52w Low $87.22 93.9% of range 52w High $156.18
50d MA $132.30 200d MA $122.42
P/E (TTM) 15.9x
EV/EBITDA -15.1x
P/B 1.6x
Debt/Equity 1.1x
ROE 10.6%
P/FCF 8.6x
RSI (14)
ATR (14)
Beta 1.38
50d MA $132.30
200d MA $122.42
Avg Volume 2.5M
About
State Street Corporation, through its subsidiaries, provides a range of financial products and services to institutional investors worldwide. The company offers investment servicing products and services, including custody; product accounting; daily pricing and administration; master trust and master custody; depotbank services; record-keeping; cash management; foreign exchange, brokerage and othe…
Recent Earnings
Date Time Est Rptd Surp Base Gap% D1% D2% D3% D4% D5% 1M% Guide ▲★
Apr 17, 2026 AMC 2.64 2.84 +7.6% 145.43 +0.8% +3.3% +5.6% +4.8% +4.0% +3.7%
Jan 16, 2026 AMC 2.84 2.97 +4.6% 128.02 -0.6% -2.1% -0.9% +0.3% -1.5% -0.3% -0.0%
Oct 17, 2025 AMC 2.64 2.78 +5.3% 111.37 +0.8% +3.5% +2.7% +1.7% +2.9% +4.3% +1.3%
Jul 15, 2025 AMC 2.35 2.53 +7.7% 102.01 +0.8% +3.0% +5.4% +6.4% +6.0% +7.5% +11.4%
Apr 17, 2025 AMC 2.00 2.04 +2.0% 81.26 -1.4% -0.8% +3.2% +5.2% +7.8% +7.5% +20.9%
Jan 17, 2025 AMC 2.29 2.60 +13.5% 97.63 +0.0% +1.4% -0.5% -0.1% +1.5% +2.7% +2.9%
Oct 15, 2024 AMC 2.12 2.26 +6.6% 91.82 +1.4% +1.2% +0.8% -0.4% -1.8% -2.1% +2.6%
Jul 16, 2024 AMC 2.03 2.15 +5.9% 84.82 +0.1% +0.6% -0.6% -0.4% -1.0% -1.2% -5.0%
Apr 12, 2024 AMC 1.50 1.69 +12.7% 75.78 +0.9% -1.1% -3.6% -3.9% -3.6% -3.2% +0.5%
Jan 19, 2024 AMC 1.81 2.04 +12.7% 75.86 +0.2% -2.0% -2.5% -2.7% -1.6% -1.0% -5.7%
Recent Analyst Ratings
Date Firm Action Grade Target Base Open Gap% D1% D2% D3% D4% D5%
Apr 21 Argus Maintains Buy → Buy $150.18 $150.47 +0.2% +2.3% +1.5% +0.7% +0.4% +2.6%
Apr 20 RBC Capital Maintains Sector Perform → Sector Perform $145.43 $146.57 +0.8% +3.3% +5.6% +4.8% +4.0% +3.7%
Apr 20 Keefe, Bruyette & Woods Maintains Outperform → Outperform $145.43 $146.57 +0.8% +3.3% +5.6% +4.8% +4.0% +3.7%
Apr 20 Truist Maintains Hold → Hold $145.43 $146.57 +0.8% +3.3% +5.6% +4.8% +4.0% +3.7%
Apr 20 Goldman Sachs Maintains Buy → Buy $145.43 $146.57 +0.8% +3.3% +5.6% +4.8% +4.0% +3.7%
Apr 20 Morgan Stanley Maintains Overweight → Overweight $145.43 $146.57 +0.8% +3.3% +5.6% +4.8% +4.0% +3.7%
Apr 9 Keefe, Bruyette & Woods Maintains Outperform → Outperform $136.13 $135.94 -0.1% +1.7% +2.4% +4.0% +4.2% +4.9%
Apr 6 BofA Securities Upgrade Underperform → Neutral $128.80 $130.73 +1.5% +1.1% +1.9% +5.7% +7.5% +8.2%
Mar 26 RBC Capital Maintains Sector Perform → Sector Perform $126.92 $125.80 -0.9% -1.0% -3.5% -2.8% -0.3% +1.0%
Jan 20 Morgan Stanley Maintains Overweight → Overweight $128.02 $127.21 -0.6% -2.1% -0.9% +0.3% -1.5% -0.3%
Recent Filings
8-K
State Street Corporation -- 8-K Filing
State Street issued notes underwritten by Morgan Stanley, expanding its debt capital structure as documented in the supplemental indenture filing.
Apr 24
8-K
Tyra Biosciences, Inc. -- 8-K Filing
Tyra Biosciences appointed a board member with significant biopharmaceutical experience, including prior roles at Blueprint Medicines (acquired by Sanofi) and other therapeutic companies.
Apr 17
8-K · 7.01 ! Medium
State Street Corporation -- 8-K 7.01: Regulation FD Disclosure
State Street disclosed first-quarter 2026 financial results and operational highlights via investor presentation, signaling upcoming earnings details during its quarterly conference call.
Apr 17
8-K
Unknown — 8-K Filing
This 8-K likely concerns State Street's asset servicing operations for a mortgage or securities pool, suggesting potential changes in loan servicing arrangements that could impact fee revenue streams.
Apr 14
8-K · 8.01 !! High
Unknown — 8-K 8.01: Material Event / Announcement
Morgan Chase's commercial mortgage securities filing suggests potential refinancing activity or debt restructuring that could affect STT's (State Street) financial stability or capital adequacy ratios if materially connected.
Apr 14
8-K · 1.01 ! Medium
Unknown — 8-K 1.01: Material Agreement
LIVG and STT signed a material agreement likely involving custody, fund administration, or financial services that could significantly impact revenue, operational scale, or strategic positioning for both parties.
Apr 10
NT 10-K !!! Very High
Unknown — Late Annual Report — Distress Signal
Late annual report filings signal potential financial or operational distress, likely triggering regulatory scrutiny and investor concern, which could pressure stock valuations downward until compliance is restored.
Apr 8
8-K · 5.02 !!! Very High
Unknown — 8-K 5.02: Executive Change
Executive departures at State Street (STT) and Invesco (PSQH) effective May 2026 create near-term leadership uncertainty and potential operational disruption, warranting caution until succession plans clarify strategic direction.
Apr 7
8-K · 8.01 !! High
Unknown — 8-K 8.01: Material Event / Announcement
A commercial mortgage securitization filing suggests State Street faces potential credit exposure to commercial real estate risks, which could impact earnings if underlying mortgage performance deteriorates.
Apr 3
8-K
Unknown — 8-K Filing
I cannot provide a meaningful analysis because the filing content is incomplete metadata/technical specifications rather than substantive financial information about State Street (STT) or Tyra Biosciences (TYRA).
Apr 2
Data updated apr 27, 2026 3:23am · Source: massive.com